Detalles de la búsqueda
1.
Differential Severe Acute Respiratory Syndrome Coronavirus 2-Specific Humoral Response in Inactivated Virus-Vaccinated, Convalescent, and Breakthrough-Infected Subjects.
J Infect Dis
; 228(7): 857-867, 2023 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37572355
2.
Safety and Immunogenicity of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in a Subgroup of Healthy Adults in Chile.
Clin Infect Dis
; 75(1): e792-e804, 2022 08 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34537835
3.
Identification of biomarkers for disease severity in nasopharyngeal secretions of infants with upper or lower respiratory tract viral infections.
Clin Exp Immunol
; 210(1): 68-78, 2022 10 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36036806
4.
Interleukin-10 Produced by Myeloid-Derived Suppressor Cells Provides Protection to Carbapenem-Resistant Klebsiella pneumoniae Sequence Type 258 by Enhancing Its Clearance in the Airways.
Infect Immun
; 87(5)2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30804104
5.
Angiotensin-(1-7) decreases skeletal muscle atrophy induced by angiotensin II through a Mas receptor-dependent mechanism.
Clin Sci (Lond)
; 128(5): 307-19, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25222828
6.
The Ang-(1-7)/Mas-1 axis attenuates the expression and signalling of TGF-ß1 induced by AngII in mouse skeletal muscle.
Clin Sci (Lond)
; 127(4): 251-64, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24588264
7.
Inhibition of the angiotensin-converting enzyme decreases skeletal muscle fibrosis in dystrophic mice by a diminution in the expression and activity of connective tissue growth factor (CTGF/CCN-2).
Cell Tissue Res
; 353(1): 173-87, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23673415
8.
Characterization of the humoral and cellular immunity induced by a recombinant BCG vaccine for the respiratory syncytial virus in healthy adults.
Front Immunol
; 14: 1215893, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37533867
9.
Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adults.
EBioMedicine
; 91: 104563, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37099842
10.
Non-capsular based immunization approaches to prevent Streptococcus pneumoniae infection.
Front Cell Infect Microbiol
; 12: 949469, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36225231
11.
Inactivated Vaccine-Induced SARS-CoV-2 Variant-Specific Immunity in Children.
mBio
; 13(6): e0131122, 2022 12 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36383021
12.
A booster dose of an inactivated SARS-CoV-2 vaccine increases neutralizing antibodies and T cells that recognize Delta and Omicron variants of concern.
medRxiv
; 2022 Feb 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35441179
13.
Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trial.
Elife
; 112022 10 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36226829
14.
A Booster Dose of CoronaVac Increases Neutralizing Antibodies and T Cells that Recognize Delta and Omicron Variants of Concern.
mBio
; 13(4): e0142322, 2022 08 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35946814
15.
Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine.
Front Immunol
; 12: 747830, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34858404
16.
Immune Profile and Clinical Outcome of Breakthrough Cases After Vaccination With an Inactivated SARS-CoV-2 Vaccine.
Front Immunol
; 12: 742914, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34659237
17.
Interim report: Safety and immunogenicity of an inactivated vaccine against SARS-CoV-2 in healthy chilean adults in a phase 3 clinical trial.
medRxiv
; 2021 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35441164
18.
Safety and immunogenicity evaluation of recombinant BCG vaccine against respiratory syncytial virus in a randomized, double-blind, placebo-controlled phase I clinical trial.
EClinicalMedicine
; 27: 100517, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33073219
19.
Cytokines in the Respiratory Airway as Biomarkers of Severity and Prognosis for Respiratory Syncytial Virus Infection: An Update.
Front Immunol
; 10: 1154, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31214165
20.
Evaluation of monoclonal antibodies that detect conserved proteins from Respiratory Syncytial Virus, Metapneumovirus and Adenovirus in human samples.
J Virol Methods
; 254: 51-64, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29410056